[MOL] RSR13 combined therapy for glioblastoma...... [01206] Medicine On Line

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[MOL] RSR13 combined therapy for glioblastoma......

DENVER, CO -- May 23, 2000 -- Allos Therapeutics, Inc. announces positive
Phase II survival results with RSR13 combined with cranial
| radiation therapy (RT) in patients with newly diagnosed glioblastoma
multiforme (GBM) brain cancer. Results were presented at the
| annual meeting of the American Society of Clinical Oncology (ASCO) meeting
in New Orleans.

We invite you to take a look at our Album.                                               
  ( Very informational, good tips, Molers pictures, art work and much more....